DocGo Inc.
جودة البيانات: 100%
DCGO
NASDAQ
Services
Health Services
KWD 0.52
▼
KWD 0.06
(-9.85%)
القيمة السوقية: 51.33 M
السعر
KWD 0.52
القيمة السوقية
51.33 M
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—
Quick Summary
النقاط الرئيسية
Revenue grew 0.27% annually over 5 years — modest growth
Earnings declined -1465.21% over the past year
Debt/Equity of 0.00 — conservative balance sheet
Generating 29.91 M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 48.01%
Capital efficient — spends only 1.41% of revenue on capex
النمو
Revenue Growth (5Y)
0.27%
أقل من متوسط القطاع (4.21%)
Revenue (1Y)-47.74%
Earnings (1Y)-1465.21%
FCF Growth (3Y)N/A
الجودة
Return on Equity
-64.25%
أقل من متوسط القطاع (-15.85%)
ROIC-47.81%
Net Margin-56.61%
Op. Margin-55.26%
الأمان
Debt / Equity
0.00
أقل من متوسط القطاع (0.39)
Current Ratio2.59
Interest CoverageN/A
التقييم
PE (TTM|NTM|2027)
-0.28 | 0.81 | 0.81
أعلى من متوسط القطاع (-1.18)
P/B Ratio0.19
EV/EBITDAN/A
Dividend YieldN/A
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Services (506 نظير)
مقارنة الأقران
مقابل وسيط قطاع Services (506 نظير)| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -0.3 | -1.2 |
| P/B | 0.2 | 1.4 |
| ROE % | -64.3 | -15.8 |
| Net Margin % | -56.6 | -18.3 |
| Rev Growth 5Y % | 0.3 | 4.2 |
| D/E | 0.0 | 0.4 |
السعر المستهدف للمحللين
5 محللين
Buy
الحالي
KWD 0.52
المستهدف
KWD 2.10
KWD 1.00
KWD 2.50
KWD 3.00
التوقعات
مكرر الربحية المستقبلي
0.81
ربحية السهم المستقبلية
KWD 0.64
نمو ربحية السهم (تقدير)
+413.6%
الإيرادات المقدّرة
319.10 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2027 |
KWD 0.64
KWD 0.04 – KWD 1.25
|
319.10 M | 2 |
| FY2026 |
KWD 0.13
-KWD 0.44 – KWD 0.69
|
298.91 M | 2 |
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| 2026 Q2 |
-KWD 0.01
-KWD 0.15 – KWD 0.13
|
73.04 M | 2 |
| 2026 Q1 |
-KWD 0.06
-KWD 0.22 – KWD 0.10
|
72.43 M | 2 |
مفاجآت الأرباح
آخر 4 أرباع
| الربع | EPS المقدر | EPS الفعلي | المفاجأة |
|---|---|---|---|
| Q42025 | -KWD 0.34 | -KWD 1.68 | -390.0% |
| Q32025 | -KWD 0.40 | -KWD 0.25 | +38.5% |
| Q22025 | -KWD 0.23 | -KWD 0.21 | +7.1% |
| Q12025 | KWD 0.03 | -KWD 0.17 | -622.1% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -47.74% | Revenue Growth (3Y) | -28.16% |
| Earnings Growth (1Y) | -1465.21% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 0.27% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 322.20 M | Net Income (TTM) | -182.40 M |
| ROE | -64.25% | ROA | -47.87% |
| Gross Margin | N/A | Operating Margin | -55.26% |
| Net Margin | -56.61% | Free Cash Flow (TTM) | 29.91 M |
| ROIC | -47.81% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 2.59 |
| Interest Coverage | N/A | Asset Turnover | 0.85 |
| Working Capital | 116.64 M | Tangible Book Value | 211.50 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.28 | Forward P/E | 0.81 |
| P/B Ratio | 0.19 | P/S Ratio | 0.16 |
| PEG Ratio | N/A | Forward PEG | 0.00 |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 0.16 | Fwd Earnings Yield | 123.46% |
| FCF Yield | 58.26% | ||
| Market Cap | 51.33 M | Enterprise Value | -21.78 M |
| Per Share | |||
| EPS (Diluted TTM) | -1.84 | Revenue / Share | 3.26 |
| FCF / Share | 0.30 | OCF / Share | 0.35 |
| EPS CAGR (1Y) | -1122.22% | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 1.41% | FCF Conversion | -16.40% |
| SBC-Adj. FCF | 12.45 M | Growth Momentum | -48.01 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 322.20 M | 616.56 M | 624.29 M | 440.52 M | — |
| Net Income | -182.40 M | 13.36 M | 10.05 M | 34.58 M | -148,751.0 |
| EPS (Diluted) | -1.84 | 0.18 | 0.06 | 0.34 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -178.03 M | 28.69 M | 15.05 M | 21.83 M | -168,830.0 |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 13.56 M | 11.59 M | 10.86 M | 5.38 M | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | 15.66 M | 15.88 M | 4.83 M | 10.57 M | — |
| Interest Expense | — | — | 1.68 M | 117,664.0 | — |
| Income Tax | 8.87 M | 14.39 M | 6.36 M | -7.96 M | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 217.10 M | 455.62 M | 490.45 M | 393.28 M | 116.07 M |
| Total Liabilities | 91.23 M | 140.44 M | 185.28 M | 114.35 M | 4.18 M |
| Shareholders' Equity | 144.01 M | 320.92 M | 300.79 M | 273.23 M | 5.00 M |
| Total Debt | 235,583.0 | 17,730.0 | 69,717.0 | — | — |
| Cash & Equivalents | 51.02 M | 89.24 M | 59.29 M | 157.34 M | 878,653.0 |
| Current Assets | 152.40 M | 304.49 M | 338.87 M | 271.08 M | 1.05 M |
| Current Liabilities | 67.49 M | 121.81 M | 170.12 M | 100.16 M | 159,850.0 |
{"event":"ticker_viewed","properties":{"ticker":"DCGO","listing_kind":"stock","pathname":"/stocks/dcgo","exchange":"NASDAQ","country":"US"}}




